加味宣白承气汤治疗痰热壅肺型老年非重症社区获得性肺炎(风温肺热病)临床研究OA
A clinical study on Jiawei Xuanbai Chengqi Tang in the treatment of senile non-severe community-acquired pneumonia of phlegm-heat obstructing the lung syndrome(wind-warm lung-heat disease)
目的:探讨加味宣白承气汤治疗痰热壅肺型老年非重症社区获得性肺炎的临床效果.方法:选择2018年9月—2019年9月昌吉州中医医院确诊的100例痰热壅肺型老年社区获得性肺炎患者作为研究对象,根据用药情况将其分为观察组与对照组,各50例.对照组给予经验性抗感染治疗,观察组在对照组基础上联合加味宣白承气汤治疗,比较两组的临床疗效.结果:治疗前,两组中医症状积分的差异无统计学意义(P＞0.05);治疗后,观察组中医症状积分低于对照组,差异有统计学意义(P＜0.05).治疗前,两组患者的体温恢复情况、白细胞计数(white blood cell count,WBC)、中性粒细胞百分数(neutrophil percentage,NEUT％)、C 反应蛋白(C-reactive protein,CRP)及降钙素原(procalcitonin,PCT)水平的差异无统计学意义(P＞0.05);治疗后,观察组的体温恢复正常用时、WBC、NEUT％、CRP水平低于对照组,差异有统计学意义(P＜0.05).治疗前,两组胸部X线片阴影水平的差异无统计学意义(P＞0.05);治疗后,观察组胸部X线片阴影总吸收率高于对照组,差异有统计学意义(P＜0.05).观察组的治疗总有效率高于对照组,差异有统计学意义(P＜0.05).结论:加味宣白承气汤能明显改善痰热壅肺型老年社区获得性肺炎的临床症状与炎性指标,促进肺部阴影吸收,疗效确切.
Objective:To evaluate the clinical efficacy of Jiawei Xuanbai Chengqi Tang(加味宣白承气汤)in treating elderly patients with non-severe community-acquired pneumonia(CAP)of the phlegm-heat obstructing the lung syndrome.Methods:A total of 100 eligible patients diagnosed between September 2018 and September 2019 were divided into an observation group(n=50)and a control group(n=50).The control group received empirical antibiotic therapy,while the observation group received additional Jiawei Xuanbai Chengqi Tang.Therapeutic outcomes were compared between the two groups.Results:Before treatment,there was no statistically significant difference in the traditional Chinese medicine(TCM)symptom scores between the two groups(P＞0.05).After treatment,the TCM symptom scores in the observation group were lower than those in the control group,with a statistically significant difference(P＜0.05).Before treatment,there were no statistically significant differences between the two groups in terms of body temperature recovery,white blood cell count(WBC),neutrophil percentage(NEUT％),C-reactive protein(CRP)and procalcitonin(PCT)levels(P＞0.05).After treatment,the body temperature recovery time,WBC,NEUT％and CRP levels in the observation group were lower than those in the control group,and the differences were statistically significant(P＜0.05).Before treatment,there was no statistically significant difference in chest X-ray shadow grade between the two groups(P＞0.05).After treatment,the total absorption rate of chest X-ray shadows in the observation group was higher than that in the control group,and the difference was statistically significant(P＜0.05).The total effective rate of treatment in the observation group was higher than that in the control group,and the difference was statistically significant(P＜0.05).Conclusion:Jiawei Xuanbai Chengqi Tang significantly improves clinical symptoms,reduces inflammatory markers,and promotes radiographic resolution of lung shadows in elderly patients with CAP of the phlegm-heat obstructing the lung syndrome,demonstrating definite clinical efficacy.
白丽娜;刘慧;郭致伟;杨立春
昌吉州中医医院,新疆 昌吉州,831100昌吉州中医医院,新疆 昌吉州,831100昌吉州中医医院,新疆 昌吉州,831100昌吉州中医医院,新疆 昌吉州,831100
医药卫生
社区获得性肺炎非重症风温肺热病痰热壅肺证加味宣白承气汤
Non-severe community-acquired pneumoniaWind-warm lung-heat diseasePhlegm-heat obstructing the lung syndromeJiawei Xuanbai Chengqi Tang
《中医临床研究》 2026 (11)
120-125,6
昌吉州科技计划项目(2018S06-02):加味宣白承气汤治疗痰热壅肺型老年非重症社区获得性肺炎(风温肺热病)临床研究.
评论